Billionaire Ken Griffin Sells Broadcom Stock and Buys an AI Stock Up 2,700% Since 2023

Ken Griffin is one of the most successful hedge fund managers in history, and he bought a small position in Palantir in the ...

Novartis Fabhalta® (iptacopan) meets Phase III primary endpoint, slows kidney function decline in patients with IgA nephropathy (IgAN)

In APPLAUSE-IgAN final analysis, Fabhalta demonstrated statistically significant, clinically meaningful improvement in estimated glomerular filtration rate (eGFR) slope vs. placebo over two years1eGFR ...